Home > Health & Beauty > Pharmaceutical

Pharmaceutical

Mesothelioma Cancer Cardio AIDS
Alternative Medicine Biotechnology Clinical Trials
Dental Diabetes FDA
Fitness & Nutrition Genetics Hospitals
Infectious Diseases Medical Devices Medical Supplies
Mental Health Nursing Oncology
Optical Pharmaceutical Radiology
Veterinary
February 11, 2012 05:12
ZURICH & AMSTERDAM--(BUSINESS WIRE)--Investment community to come out in full force at BIO-Europe Spring® 2012
World  World      Pharmaceutical  Pharmaceutical
February 11, 2012 02:58
ZURIGO e AMSTERDAM--(BUSINESS WIRE)--Biopharm si prepara per BIO-Europe Spring®, la conferenza primaverile di partenariato nel settore delle scienze della vita organizzata da EBD Group che si svolgerà ad Amsterdam dal 19 al 21 marzo 2012 presso l'Amsterdam RAI Convention Center. BIO-Europe Spring...
World  World      Pharmaceutical  Pharmaceutical
February 11, 2012 02:22
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (NASDAQ:EXEL) today announced that Michael M. Morrissey, Ph.D., the company’s president and chief executive officer, will present at the 14th annual BIO CEO & Investor Conference at 8:30 a.m. EST / 5:30 a.m. PST on Tuesday, February 14,...
World  World      Pharmaceutical  Pharmaceutical
February 11, 2012 02:13
NEW YORK--(BUSINESS WIRE)--Fitch Ratings believes the US Federal Drug and Administration's proposed biosimilar pathway regulations provide the necessary framework to allow drug companies to develop generic versions of biologically-derived medicines, thus granting patients access to cheaper versio...
World  World      Pharmaceutical  Pharmaceutical
February 11, 2012 02:00
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview at the 14th Annual BIO CEO & Investor Conference on Tuesday, February 14, 2012 at 3:30 p.m. ET and at the Leerink S...
World  World      Pharmaceutical  Pharmaceutical
February 11, 2012 02:00
ROCKVILLE, Md.--(BUSINESS WIRE)--Human Genome Sciences, Inc. (NASDAQ: HGSI) announced today that its presentation at the 14th Annual BIO CEO & Investor Conference will be webcast and may be accessed at www.hgsi.com. A member of Human Genome Sciences’ senior management team will present a corporat...
World  World      Pharmaceutical  Pharmaceutical